Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: POP BIOTECHNOLOGIES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2025-09-29
Current total value of award: $599806
Description: POP TECHNOLOGIES, INC., "MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE".